FDA Inspection 1030563 — Alain Ravaud, MD, PhD
The FDA completed an inspection of Alain Ravaud, MD, PhD on Jul 28, 2017 in Bordeaux Cedex. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 28, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bordeaux Cedex (France)
Additional details
Clinical Investigator (CI)